474 results on '"Hirshberg, Boaz"'
Search Results
52. Efficacy and safety of saxagliptin as monotherapy in patients with type 2 diabetes: a pooled analysis.: 84E.
53. Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin
54. Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial
55. Radiologic aspects of islet cell transplantation
56. Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design
57. State of the Art: Islet Transplantation for the Cure of Type 1 Diabetes Mellitus
58. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
59. Cardiovascular Outcome Studies With Novel Antidiabetes Agents: Scientific and Operational Considerations
60. Survival after pancreas transplantation in patients with diabetes and preserved kidney function
61. Ectopic luteinizing hormone secretion and anovulation
62. Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs
63. Effects of cotadutide on biomarkers of non-alcoholic steatohepatitis in overweight or obese subjects with type 2 diabetes mellitus: a 54-week analysis of a randomized phase 2b study
64. Benefits of simultaneous islet-kidney transplantation versus simultaneous pancreas-kidney transplantation
65. Lessons learned from the International trial of the Edmonton protocol for islet transplantation
66. Can we justify living donor islet transplantation?
67. Modulation of 11β-Hydroxysteroid Dehydrogenase (11βHSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11βHSD1 Inhibitor
68. Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design
69. Can statins reduce the incidence of new-onset diabetes post transplantation?
70. Malignant insulinoma: Spectrum of unusual clinical features
71. Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression
72. Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: The National Institutes of Health experience
73. Glucagon-Like Peptide 1 Inhibits Cell Apoptosis and Improves Glucose Responsiveness of Freshly Isolated Human Islets
74. Sirolimus-Induced Interstitial Pneumonitis in an Islet Transplant Recipient
75. Brief Report: Ectopic Luteinizing Hormone Secretion and Anovulation
76. Histopathological Study of Intrahepatic Islets Transplanted in the Nonhuman Primate Model Using Edmonton Protocol Immunosuppression
77. Pancreatic Islet Transplantation Using the Nonhuman Primate (Rhesus) Model Predicts That the Portal Vein Is Superior to the Celiac Artery as the Islet Infusion Site
78. A Proinsulin Gene Splice Variant with Increased Translation Efficiency Is Expressed in Human Pancreatic Islets
79. Efficacy and Toxicity of a Protocol Using Sirolimus, Tacrolimus and Daclizumab in a Nonhuman Primate Renal Allotransplant Model
80. The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus-Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study
81. Preclinical evaluation of tolerance induction protocols and islet transplantation in non-human primates
82. Nesidioblastosis in Adults: A Clinical Enigmag
83. Repaglinide-Induced Factitious Hypoglycemia
84. Safety of low dose methotrexate in elderly patients with rheumatoid arthritis
85. Forty-Eight-Hour Fast: The Diagnostic Test for Insulinoma
86. Renal nitric oxide production during the early phase of experimental diabetes mellitus
87. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome
88. Recovery From Blast Lung Injury*: One-Year Follow-up
89. Factors Predicting Mortality of Patients With Lung Abscess*
90. Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist
91. 1010-P: Effects of MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity, on Amino Acids, Ketones, and Free Fatty Acids
92. 1017-P: Continuous Glucose Monitoring Reveals Comprehensive Glucose Control with MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity
93. 988-P: MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity, Promotes a Dose-Dependent Increase in Gastric Emptying Time
94. Randomised, phase 1, dose-finding study of MEDI4166, a PCSK9 antibody and GLP-1 analogue fusion molecule, in overweight or obese patients with type 2 diabetes mellitus
95. Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure
96. Hemoptysis: Etiology, Evaluation, and Outcome in a Tertiary Referral Hospital*
97. The syndrome of inappropriate antidiuretic hormone secretion in the elderly
98. The Cardinal Features of Recurrent Autoimmunity in Simultaneous Pancreas-Kidney Transplant Recipients
99. Implications of the 2008 update from the collaborative islet transplant registry
100. MOESM1 of Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.